BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24100364)

  • 1. Ocular manifestations of drug and alcohol abuse.
    Peragallo J; Biousse V; Newman NJ
    Curr Opin Ophthalmol; 2013 Nov; 24(6):566-73. PubMed ID: 24100364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuro-ophthalmologic side-effects of systemic medications.
    Pula JH; Kao AM; Kattah JC
    Curr Opin Ophthalmol; 2013 Nov; 24(6):540-9. PubMed ID: 24100367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ophthalmic adverse drug reactions to systemic drugs: a systematic review.
    Miguel A; Henriques F; Azevedo LF; Pereira AC
    Pharmacoepidemiol Drug Saf; 2014 Mar; 23(3):221-33. PubMed ID: 24464938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol and Drug Use in European University Health Science Students: Relationship with Self-Care Ability.
    Colomer-Pérez N; Chover-Sierra E; Navarro-Martínez R; Andriusevičienė V; Vlachou E; Cauli O
    Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31835685
    [No Abstract]   [Full Text] [Related]  

  • 6. Some ocular manifestations of systemic drug abuse.
    Urey JC
    J Am Optom Assoc; 1991 Nov; 62(11):832-42. PubMed ID: 1813511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Substance use, affective problems and personality traits: test of two association models].
    Chakroun N; Doron J; Swendsen J
    Encephale; 2004; 30(6):564-9. PubMed ID: 15738859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs of abuse and ocular effects.
    Proulx V; Tousignant B
    Clin Exp Optom; 2021 Jul; 104(5):567-578. PubMed ID: 33722158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical diagnosis and treatment recommendations for ocular toxicities of targeted therapy and immune checkpoint inhibitor therapy.
    Liu X; Wang Z; Zhao C; Wang H; Guo X; Zhou J; Duan L; Si X; Zhang L; Li Y; Wang M; Zhang M; Zhang L
    Thorac Cancer; 2020 Mar; 11(3):810-818. PubMed ID: 32017399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adverse Drug Reactions in Ophthalmology--Update 2015/2016].
    Schlote T; Kellner U
    Klin Monbl Augenheilkd; 2016 Feb; 233(2):203-16; quiz 217-99. PubMed ID: 26878736
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for alcohol and drug abuse.
    Schorling JB; Buchsbaum D
    Med Clin North Am; 1997 Jul; 81(4):845-65. PubMed ID: 9222257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced ocular disorders.
    Li J; Tripathi RC; Tripathi BJ
    Drug Saf; 2008; 31(2):127-41. PubMed ID: 18217789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early recognition of chemical dependence.
    Maly RC
    Prim Care; 1993 Mar; 20(1):33-50. PubMed ID: 8464947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMPI substance abuse scales on drug addicts with and without concurrent alcoholism.
    Craig RJ
    J Pers Assess; 1984 Oct; 48(5):495-9. PubMed ID: 6502447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician impairment by substance abuse.
    O'Connor PG; Spickard A
    Med Clin North Am; 1997 Jul; 81(4):1037-52. PubMed ID: 9222267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Not for human consumption": a review of emerging designer drugs.
    Musselman ME; Hampton JP
    Pharmacotherapy; 2014 Jul; 34(7):745-57. PubMed ID: 24710806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuro-ophthalmic manifestations of the phakomatoses.
    Douglas KAA; Douglas VP; Cestari DM
    Curr Opin Ophthalmol; 2019 Nov; 30(6):434-442. PubMed ID: 31464700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reactions.
    Seagrave Z; Bamba S
    Dis Mon; 2017 Feb; 63(2):49-53. PubMed ID: 28034457
    [No Abstract]   [Full Text] [Related]  

  • 19. Patients who use alcohol or other drugs: what to look for.
    Steinberg JR
    Md Med J; 1994 Jan; 43(1):41-4. PubMed ID: 8183083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inherent Dangers of Using Non-US Food and Drug Administration-Approved Substances of Abuse.
    White CM; Browne T; Nafziger AN
    J Clin Pharmacol; 2021 Aug; 61 Suppl 2():S129-S141. PubMed ID: 34396559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.